Dataset Viewer
Auto-converted to Parquet Duplicate
registry_id
stringlengths
17
17
year
int64
1.99k
2.02k
age
int64
0
95
age_group
stringclasses
8 values
sex
stringclasses
2 values
cancer_type
stringclasses
16 values
morphology
stringclasses
8 values
grade
stringclasses
5 values
basis_of_diagnosis
stringclasses
5 values
residence
stringclasses
3 values
vital_status
stringclasses
3 values
survival_months
float64
0
60
scenario
stringclasses
1 value
UG-KLA-2009-00001
2,009
4
0-14
Male
Oesophagus
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
37.8
moderate_burden
UG-KLA-2016-00002
2,016
43
35-44
Male
Non-Hodgkin lymphoma
Squamous cell carcinoma
Moderately differentiated (Grade II)
Death certificate only
peri-urban
Dead
14
moderate_burden
UG-KLA-2017-00003
2,017
94
75+
Female
Cervix uteri
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
56
moderate_burden
UG-KLA-1993-00004
1,993
54
45-54
Female
Cervix uteri
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
13.2
moderate_burden
UG-KLA-2008-00005
2,008
63
55-64
Male
Liver
Lymphoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
47.2
moderate_burden
UG-KLA-1997-00006
1,997
65
65-74
Male
Non-Hodgkin lymphoma
Sarcoma (incl. KS)
Undifferentiated (Grade IV)
Imaging + clinical
Rural
Alive
27
moderate_burden
UG-KLA-1991-00007
1,991
62
55-64
Male
Other
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
42.6
moderate_burden
UG-KLA-2010-00008
2,010
70
65-74
Female
Thyroid
Sarcoma (incl. KS)
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
12.3
moderate_burden
UG-KLA-2014-00009
2,014
50
45-54
Female
Thyroid
Squamous cell carcinoma
Unknown
Microscopy (histology/cytology)
peri-urban
Alive
26.8
moderate_burden
UG-KLA-2019-00010
2,019
41
35-44
Female
Thyroid
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Death certificate only
Rural
Alive
37
moderate_burden
UG-KLA-1998-00011
1,998
73
65-74
Male
Liver
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
peri-urban
Dead
58.1
moderate_burden
UG-KLA-2015-00012
2,015
54
45-54
Female
Other
Sarcoma (incl. KS)
Poorly differentiated (Grade III)
Imaging + clinical
peri-urban
Dead
5.4
moderate_burden
UG-KLA-2016-00013
2,016
54
45-54
Female
Other
Sarcoma (incl. KS)
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
0.6
moderate_burden
UG-KLA-2014-00014
2,014
34
25-34
Male
Liver
Sarcoma (incl. KS)
Well differentiated (Grade I)
Microscopy (histology/cytology)
Rural
Dead
27.5
moderate_burden
UG-KLA-1999-00015
1,999
33
25-34
Female
Other
Squamous cell carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
14.3
moderate_burden
UG-KLA-2014-00016
2,014
71
65-74
Female
Other
Unspecified
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Rural
Alive
60
moderate_burden
UG-KLA-1998-00017
1,998
54
45-54
Male
Kaposi sarcoma
Other specified
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
32.7
moderate_burden
UG-KLA-2013-00018
2,013
38
35-44
Female
Other
Adenocarcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
10.4
moderate_burden
UG-KLA-2001-00019
2,001
58
55-64
Male
Oesophagus
Lymphoma
Unknown
Microscopy (histology/cytology)
Urban (Kampala)
Alive
60
moderate_burden
UG-KLA-2009-00020
2,009
64
55-64
Female
Cervix uteri
Lymphoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
peri-urban
Dead
20.4
moderate_burden
UG-KLA-2006-00021
2,006
62
55-64
Male
Non-Hodgkin lymphoma
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
15.1
moderate_burden
UG-KLA-2013-00022
2,013
64
55-64
Female
Cervix uteri
Squamous cell carcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
peri-urban
Alive
20.4
moderate_burden
UG-KLA-2016-00023
2,016
47
45-54
Male
Prostate
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
30.6
moderate_burden
UG-KLA-2014-00024
2,014
67
65-74
Female
Cervix uteri
Squamous cell carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
19.5
moderate_burden
UG-KLA-2006-00025
2,006
37
35-44
Female
Breast
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
peri-urban
Dead
2.3
moderate_burden
UG-KLA-1998-00026
1,998
63
55-64
Female
Cervix uteri
Squamous cell carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Rural
Alive
19
moderate_burden
UG-KLA-2017-00027
2,017
61
55-64
Male
Non-Hodgkin lymphoma
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
peri-urban
Dead
20.3
moderate_burden
UG-KLA-2003-00028
2,003
36
35-44
Male
Kaposi sarcoma
Sarcoma (incl. KS)
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
4.5
moderate_burden
UG-KLA-2005-00029
2,005
38
35-44
Female
Other
Leukemia
Well differentiated (Grade I)
Microscopy (histology/cytology)
Rural
Dead
20.6
moderate_burden
UG-KLA-2013-00030
2,013
49
45-54
Female
Thyroid
Sarcoma (incl. KS)
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Rural
Alive
4.4
moderate_burden
UG-KLA-2009-00031
2,009
50
45-54
Female
Cervix uteri
Leukemia
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
4.3
moderate_burden
UG-KLA-2010-00032
2,010
72
65-74
Female
Breast
Sarcoma (incl. KS)
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
25.8
moderate_burden
UG-KLA-1999-00033
1,999
54
45-54
Male
Other
Sarcoma (incl. KS)
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
60
moderate_burden
UG-KLA-1997-00034
1,997
8
0-14
Female
Breast
Sarcoma (incl. KS)
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
peri-urban
Dead
1.3
moderate_burden
UG-KLA-2011-00035
2,011
32
25-34
Female
Other
Squamous cell carcinoma
Moderately differentiated (Grade II)
Clinical only
peri-urban
Alive
35.5
moderate_burden
UG-KLA-2014-00036
2,014
68
65-74
Female
Breast
Sarcoma (incl. KS)
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
15.2
moderate_burden
UG-KLA-1998-00037
1,998
42
35-44
Male
Prostate
Adenocarcinoma
Undifferentiated (Grade IV)
Imaging + clinical
Urban (Kampala)
Alive
60
moderate_burden
UG-KLA-1994-00038
1,994
35
35-44
Female
Other
Adenocarcinoma
Moderately differentiated (Grade II)
Clinical only
Urban (Kampala)
Dead
0.4
moderate_burden
UG-KLA-2018-00039
2,018
44
35-44
Female
Other
Lymphoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Lost to follow-up
33.7
moderate_burden
UG-KLA-2004-00040
2,004
63
55-64
Male
Other
Lymphoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
7.7
moderate_burden
UG-KLA-1996-00041
1,996
44
35-44
Female
Breast
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Lost to follow-up
11
moderate_burden
UG-KLA-2006-00042
2,006
58
55-64
Female
Other
Squamous cell carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
peri-urban
Alive
11.4
moderate_burden
UG-KLA-2006-00043
2,006
53
45-54
Female
Breast
Adenocarcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
18.8
moderate_burden
UG-KLA-2015-00044
2,015
44
35-44
Female
Cervix uteri
Non-keratinizing carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Urban (Kampala)
Lost to follow-up
52.2
moderate_burden
UG-KLA-2003-00045
2,003
25
25-34
Female
Corpus uteri
Sarcoma (incl. KS)
Moderately differentiated (Grade II)
Imaging + clinical
Rural
Alive
1.1
moderate_burden
UG-KLA-2001-00046
2,001
45
45-54
Male
Hodgkin lymphoma
Squamous cell carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
33.8
moderate_burden
UG-KLA-2015-00047
2,015
41
35-44
Female
Cervix uteri
Non-keratinizing carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
31.4
moderate_burden
UG-KLA-1995-00048
1,995
50
45-54
Female
Other
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
peri-urban
Alive
45.8
moderate_burden
UG-KLA-2009-00049
2,009
72
65-74
Female
Corpus uteri
Squamous cell carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
9.8
moderate_burden
UG-KLA-2009-00050
2,009
64
55-64
Female
Breast
Squamous cell carcinoma
Undifferentiated (Grade IV)
Imaging + clinical
Urban (Kampala)
Alive
59.5
moderate_burden
UG-KLA-2001-00051
2,001
55
55-64
Female
Cervix uteri
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
9.5
moderate_burden
UG-KLA-2010-00052
2,010
38
35-44
Female
Other
Lymphoma
Poorly differentiated (Grade III)
Imaging + clinical
peri-urban
Alive
26.7
moderate_burden
UG-KLA-2008-00053
2,008
15
15-24
Male
Prostate
Lymphoma
Poorly differentiated (Grade III)
Clinical only
Urban (Kampala)
Lost to follow-up
4
moderate_burden
UG-KLA-2010-00054
2,010
52
45-54
Male
Liver
Sarcoma (incl. KS)
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
peri-urban
Alive
8.9
moderate_burden
UG-KLA-2014-00055
2,014
43
35-44
Male
Other
Sarcoma (incl. KS)
Unknown
Imaging + clinical
Rural
Alive
21.5
moderate_burden
UG-KLA-2016-00056
2,016
57
55-64
Female
Breast
Squamous cell carcinoma
Poorly differentiated (Grade III)
Death certificate only
peri-urban
Alive
25
moderate_burden
UG-KLA-2009-00057
2,009
38
35-44
Female
Breast
Adenocarcinoma
Well differentiated (Grade I)
Imaging + clinical
peri-urban
Alive
60
moderate_burden
UG-KLA-2003-00058
2,003
60
55-64
Female
Cervix uteri
Adenocarcinoma
Poorly differentiated (Grade III)
Imaging + clinical
Urban (Kampala)
Alive
6.4
moderate_burden
UG-KLA-2001-00059
2,001
48
45-54
Male
Prostate
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Clinical only
Urban (Kampala)
Dead
46.1
moderate_burden
UG-KLA-2012-00060
2,012
55
55-64
Female
Other
Squamous cell carcinoma
Unknown
Clinical only
Urban (Kampala)
Alive
6.4
moderate_burden
UG-KLA-2010-00061
2,010
48
45-54
Male
Kaposi sarcoma
Adenocarcinoma
Undifferentiated (Grade IV)
Clinical only
Rural
Alive
2.5
moderate_burden
UG-KLA-2010-00062
2,010
29
25-34
Female
Ovary
Sarcoma (incl. KS)
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
peri-urban
Alive
9.6
moderate_burden
UG-KLA-2013-00063
2,013
71
65-74
Male
Leukemia
Sarcoma (incl. KS)
Well differentiated (Grade I)
Microscopy (histology/cytology)
peri-urban
Dead
3.8
moderate_burden
UG-KLA-2016-00064
2,016
57
55-64
Male
Kaposi sarcoma
Adenocarcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
peri-urban
Alive
7.1
moderate_burden
UG-KLA-1996-00065
1,996
72
65-74
Female
Cervix uteri
Adenocarcinoma
Moderately differentiated (Grade II)
Imaging + clinical
Urban (Kampala)
Lost to follow-up
15.6
moderate_burden
UG-KLA-2003-00066
2,003
61
55-64
Female
Cervix uteri
Sarcoma (incl. KS)
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
5.1
moderate_burden
UG-KLA-2009-00067
2,009
62
55-64
Female
Thyroid
Squamous cell carcinoma
Well differentiated (Grade I)
Imaging + clinical
peri-urban
Alive
54
moderate_burden
UG-KLA-2001-00068
2,001
26
25-34
Female
Breast
Squamous cell carcinoma
Poorly differentiated (Grade III)
Death certificate only
Urban (Kampala)
Lost to follow-up
43.2
moderate_burden
UG-KLA-2017-00069
2,017
58
55-64
Female
Cervix uteri
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
25.1
moderate_burden
UG-KLA-2003-00070
2,003
62
55-64
Female
Other
Unspecified
Undifferentiated (Grade IV)
Other
Urban (Kampala)
Dead
7.8
moderate_burden
UG-KLA-2007-00071
2,007
73
65-74
Female
Breast
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
13.4
moderate_burden
UG-KLA-2001-00072
2,001
48
45-54
Male
Prostate
Adenocarcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
31.3
moderate_burden
UG-KLA-2014-00073
2,014
70
65-74
Male
Kaposi sarcoma
Leukemia
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
8.3
moderate_burden
UG-KLA-2003-00074
2,003
59
55-64
Female
Breast
Sarcoma (incl. KS)
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
peri-urban
Dead
7
moderate_burden
UG-KLA-1999-00075
1,999
43
35-44
Female
Cervix uteri
Sarcoma (incl. KS)
Well differentiated (Grade I)
Microscopy (histology/cytology)
peri-urban
Lost to follow-up
55.7
moderate_burden
UG-KLA-1999-00076
1,999
31
25-34
Female
Cervix uteri
Lymphoma
Moderately differentiated (Grade II)
Imaging + clinical
peri-urban
Dead
13.1
moderate_burden
UG-KLA-2001-00077
2,001
57
55-64
Male
Other
Adenocarcinoma
Undifferentiated (Grade IV)
Clinical only
Rural
Dead
8.4
moderate_burden
UG-KLA-2007-00078
2,007
43
35-44
Female
Other
Squamous cell carcinoma
Moderately differentiated (Grade II)
Other
Urban (Kampala)
Alive
24.3
moderate_burden
UG-KLA-2001-00079
2,001
61
55-64
Male
Kaposi sarcoma
Sarcoma (incl. KS)
Unknown
Death certificate only
peri-urban
Alive
60
moderate_burden
UG-KLA-2004-00080
2,004
18
15-24
Male
Prostate
Squamous cell carcinoma
Well differentiated (Grade I)
Death certificate only
Rural
Alive
15.2
moderate_burden
UG-KLA-2011-00081
2,011
48
45-54
Male
Other
Sarcoma (incl. KS)
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
2.3
moderate_burden
UG-KLA-1999-00082
1,999
42
35-44
Female
Cervix uteri
Sarcoma (incl. KS)
Well differentiated (Grade I)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
2.8
moderate_burden
UG-KLA-2005-00083
2,005
4
0-14
Female
Breast
Lymphoma
Poorly differentiated (Grade III)
Death certificate only
Urban (Kampala)
Alive
11.7
moderate_burden
UG-KLA-2014-00084
2,014
48
45-54
Female
Breast
Sarcoma (incl. KS)
Well differentiated (Grade I)
Microscopy (histology/cytology)
Rural
Dead
1.6
moderate_burden
UG-KLA-2008-00085
2,008
52
45-54
Male
Stomach
Sarcoma (incl. KS)
Moderately differentiated (Grade II)
Death certificate only
peri-urban
Alive
22.4
moderate_burden
UG-KLA-2016-00086
2,016
71
65-74
Male
Other
Sarcoma (incl. KS)
Unknown
Microscopy (histology/cytology)
peri-urban
Alive
33.5
moderate_burden
UG-KLA-2014-00087
2,014
71
65-74
Male
Non-Hodgkin lymphoma
Squamous cell carcinoma
Moderately differentiated (Grade II)
Imaging + clinical
Urban (Kampala)
Alive
1.8
moderate_burden
UG-KLA-2005-00088
2,005
20
15-24
Female
Corpus uteri
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Clinical only
Urban (Kampala)
Alive
16.2
moderate_burden
UG-KLA-2010-00089
2,010
60
55-64
Female
Other
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Clinical only
Urban (Kampala)
Alive
0.4
moderate_burden
UG-KLA-1997-00090
1,997
45
45-54
Female
Cervix uteri
Adenocarcinoma
Poorly differentiated (Grade III)
Imaging + clinical
Urban (Kampala)
Dead
50.5
moderate_burden
UG-KLA-1992-00091
1,992
72
65-74
Female
Cervix uteri
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Rural
Alive
2.9
moderate_burden
UG-KLA-2010-00092
2,010
94
75+
Female
Cervix uteri
Squamous cell carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
18.6
moderate_burden
UG-KLA-2004-00093
2,004
23
15-24
Female
Thyroid
Lymphoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
18.4
moderate_burden
UG-KLA-1995-00094
1,995
61
55-64
Female
Breast
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Imaging + clinical
peri-urban
Alive
6
moderate_burden
UG-KLA-2002-00095
2,002
86
75+
Female
Other
Squamous cell carcinoma
Unknown
Microscopy (histology/cytology)
Urban (Kampala)
Dead
40.6
moderate_burden
UG-KLA-1995-00096
1,995
52
45-54
Female
Cervix uteri
Lymphoma
Undifferentiated (Grade IV)
Clinical only
Urban (Kampala)
Dead
23.5
moderate_burden
UG-KLA-2000-00097
2,000
19
15-24
Male
Other
Adenocarcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
peri-urban
Alive
46.3
moderate_burden
UG-KLA-1999-00098
1,999
12
0-14
Female
Breast
Squamous cell carcinoma
Unknown
Clinical only
Urban (Kampala)
Dead
15.5
moderate_burden
UG-KLA-2004-00099
2,004
74
65-74
Female
Thyroid
Sarcoma (incl. KS)
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Urban (Kampala)
Dead
4.6
moderate_burden
UG-KLA-1991-00100
1,991
27
25-34
Female
Breast
Squamous cell carcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Urban (Kampala)
Alive
31.3
moderate_burden
End of preview. Expand in Data Studio

⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference.

Uganda Cancer Registry - Kampala

Abstract

This synthetic dataset represents population-based cancer registry data for kampala and is designed to address the significant data gap in cancer research for sub-Saharan Africa. The dataset contains 3,200-4,800 per scenario records per scenario with key epidemiological parameters grounded in GLOBOCAN 2022 estimates, WHO reports, and peer-reviewed literature from the African Cancer Registry Network (AFCRN).

The age-standardized incidence rate (ASIR) of Uganda Cancer Registry in the target population is approximately 104.5 per 100,000 population (GLOBOCAN 2022). This dataset provides training data for cancer epidemiology modeling, health systems research, and machine learning applications in oncology.

1. Introduction

1.1 Problem Statement

Cancer incidence in sub-Saharan Africa is rising rapidly, with estimated new cases reaching over 1 million annually by 2030. However, the region faces a critical shortage of granular cancer data for research, policy development, and health system planning. Population-based cancer registries cover less than 5% of the African population, creating significant gaps in understanding the true burden of disease.

1.2 Data Gap

  • Limited population-based registry data outside major cities
  • Missing survival and outcome data from most facilities
  • Underrepresentation of pediatric and rare cancers
  • Lack of treatment access and outcome metrics

1.3 Purpose

This dataset supports:

  • Cancer burden estimation and projection modeling
  • Health system capacity planning
  • Machine learning for risk prediction and triage
  • Epidemiological research on cancer patterns
  • Policy development for cancer control programs

2. Methodology

2.1 Target Population

  • Geographic scope: Uganda
  • Population represented: Urban and rural populations
  • Time period: Variable by data source (2010-2025)

2.2 Variable Selection

Variables were selected based on:

  • IARC/WHO cancer registry standards
  • Data availability in African cancer registries
  • Clinical relevance for cancer control

2.3 Epidemiological Parameterization

All parameters are derived from:

  • GLOBOCAN 2022 (IARC)
  • WHO Cancer Reports
  • African Cancer Registry Network (AFCRN)
  • DHS/MICS survey data
  • Peer-reviewed literature

2.4 Scenario Design

Scenario Description Records
low_burden Low cancer burden setting Varies by dataset
moderate_burden Standard burden setting Varies by dataset
high_burden High burden / late presentation Varies by dataset

2.5 Generation Process

Generation follows a conditional sampling approach based on directed acyclic graphs (DAGs) representing causal relationships between variables:

  1. Sample demographic variables (age, sex, location)
  2. Sample cancer type conditional on demographics
  3. Sample clinical variables (stage, morphology, grade)
  4. Sample treatment and outcome variables
  5. Derive survival times from outcome models

3. Dataset Description

3.1 Key Variables

Population-based cancer registry data for Kampala

3.2 Data Quality

  • All categorical distributions validated against published literature
  • Continuous variables modeled with appropriate statistical distributions
  • Survival times based on exponential models with literature-derived parameters

4. Validation

4.1 Prevalence Verification

All prevalence values are validated against GLOBOCAN 2022 and published registry reports.

4.2 Distribution Quality

  • Age and sex distributions match expected patterns
  • Cancer type frequencies align with regional estimates

4.3 Clinical Plausibility

  • No biologically impossible combinations
  • Treatment patterns consistent with resource-limited settings

5. Usage

5.1 Loading with HuggingFace

from datasets import load_dataset
ds = load_dataset("electricsheepafrica/uganda-cancer-kampala", "moderate_burden")

5.2 Loading from CSV

import pandas as pd
df = pd.read_csv("uganda_cancer_kampala_moderate_burden.csv")

6. Limitations

  • Synthetic data: Generated from aggregated statistics, not individual patient records
  • Simplified correlations: May not capture complex dependencies
  • Not for clinical use: Designed for research and ML training only

7. References

  1. GLOBOCAN 2022. IARC Cancer Observatory.
  2. African Cancer Registry Network (AFCRN).
  3. WHO Cancer Control Reports.
  4. DHS/MICS Survey Data.

Citation

@dataset{uganda_cancer_kampala,
  title={Uganda Cancer Registry - Kampala},
  author={Electric Sheep Africa},
  year={2025},
  publisher={HuggingFace},
  dataset_url={https://huggingface.co/datasets/electricsheepafrica/uganda-cancer-kampala}
}

License

CC-BY-4.0

Downloads last month
54